Site 108 — Los Angeles, California

Public research footprint of Site 108, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Moderate to Severe Plaque Psoriasis · Non-erosive Reflux Disease · Immunoglobulin A Nephropathy · Advanced Solid Tumor

Recently updated registry entries

NCT05425940 — Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal… (Active Not Recruiting)
NCT05248646 — Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) (Active Not Recruiting)
NCT02291861 — Addressing Involuntary Movements in Tardive Dyskinesia (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Site 108?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.